Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Novel alkaloid derivatives with potential anticancer properties

Dec. 27, 2021

Researchers describe first dual IDO-1/2 inhibitor with notable activity in vitro and in vivo

Dec. 27, 2021

Gene expression of extramedullary multiple myeloma samples points to new targets

Dec. 24, 2021

New USP30 inhibitors identified at Mission Therapeutics

Dec. 24, 2021

Janssen Pharmaceutica synthesizes new Mcl-1 inhibitors

Dec. 24, 2021

Dual PI3K/BRD4 inhibitors divulged by Monash University, Peter MacCallum Cancer Centre

Dec. 24, 2021

Broader look reveals more contributions to chemotherapy damage

Dec. 23, 2021

KSQ Therapeutics synthesizes USP1 inhibitors

Dec. 23, 2021

Gilead Sciences identifies new LPAR1 antagonists

Dec. 23, 2021

Biomimetic synthesis of compounds from naturally abundant arglabin

Dec. 23, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...